Cutting Edge A: A conditionally active form of STAT6 can mimic certain effects of IL-4

Journal of Immunology

Volumn 161, Issue 3, 1998, Pages 1074-1077

  Kamogawa, Yumiko ^a   Lee, Hyun Jun ^a   Johnston, James A ^a   McMahon, Martin ^a   O'Garra, Anne ^a   Arai, Naoko ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; CD23 ANTIGEN; ESTROGEN RECEPTOR; HYBRID PROTEIN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; 4-HYDROXYTAMOXIFEN; DNA BINDING PROTEIN; DRUG DERIVATIVE; GAMMA INTERFERON; IMMUNOGLOBULIN E RECEPTOR; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; STAT1 PROTEIN, MOUSE; STAT6 PROTEIN; STAT6 PROTEIN, HUMAN; STAT6 PROTEIN, MOUSE; TAMOXIFEN; TRANSACTIVATOR PROTEIN; TYROSINE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HORMONE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RECEPTOR GENE; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; DRUG POTENTIATION; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; RETROVIRUS; SYNTHESIS; TRANSACTIVATION; UPREGULATION;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; GENETIC VECTORS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MICE; PHOSPHORYLATION; RECEPTORS, IGE; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; TAMOXIFEN; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TYROSINE; UP-REGULATION;

EID: 0032133157     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Keegan, A. D., K. Nelms, L. M. Wang, J. H. Pierce. and W. E. Paul. 1994. Interleukin 4 receptor: signaling mechanisms. Immunol. Today 15:423.
2. Schindler, C., and J. E. Darnell, Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621.
3. Quelle, F. W., K. Shimoda, W. Thierfelder, C. Fischer, A. Kim, S. M. Ruben, J. L. Cleveland, J. H. Pierce, A. D. Keegan, K. Nelms, W. Paul, and J. Ihle. 1995. Cloning of murine STAT6 and human STAT6, STAT proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15:3336.
4. Hou, J., U. Schindler, W. J. Henzel, T. C. Ho, M. Brasseur, and S. L. McKnight. 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701.
5. Chen, X. H., B. K. Patel, L. M. Wang, M. Frankel, N. Ellmore, R. A. Flavell, W. J. LaRochelle, and J. H. Pierce. 1997. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules. J. Biol. Chem. 272:6556.
6. Mikita, T., D. Campbell, P. Wu, K. Williamson, and U. Schindler. 1996. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol. Cell. Biol. 16:5811.
7. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627.
8. Shimoda, K., D. J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630.
9. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313.
10. Danielian, P. S., R. White, S. A. Hoare, S. E. Fawell, and M. G. Parker. 1993. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol. Endocrinol. 7:232.
11. Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686.
12. Pritchard, C. A., M. L. Samuels, E. Bosch, and M. McMahon. 1995. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in National Institutes of Health 3T3 cells. Mol. Cell. Biol. 15:6430.
13. Onishi, M., S. Kinoshita, Y. Morikawa, A. Shibuya, J. Phillips, L. L. Lanier, D. M. German, G. P. Nolan, A. Miyajima, and T. Kitamura. 1996. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24:324.
14. Takebe, Y., M. Seiki, J. Fujisawa, P. Hoy, K. Yokota, K. Arai, M. Yoshida, and N. Arai. 1988. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:466.
15. Migone, T. S., J. X. Lin, A. Cereseto, J. C. Mulloy, J. J. O'Shea, G. Franchini, and W. J. Leonard. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79.
16. Masuda, E. S., J. Liu, R. Imamura, S. I. Imai, K. I. Arai, and N. Arai. 1997. Control of NFATx1 nuclear translocation by a calcineurin-regulated inhibitory domain. Mol. Cell. Biol. 17:2066.
17. Rothman, P., S. C. Li, B. Gorham, L. Glimcher, F. Alt, and M. Boothby. 1991. Identification of a conserved lipopolysaccharide-plus-interleukin-4-responsive element located at the promoter of germ line ε transcripts. Mol. Cell. Biol. 11:5551.
18. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630.
19. Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17:5598.
20. Kikutani, H., M. Suemura, H. Owaki, H. Nakamura, R. Sato, K. Yamasaki, E. L. Barsumian, R. R. Hardy, and T. Kishimoto. 1986. Fcε receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J. Exp. Med. 164:1455.
21. Picard, D., S. J. Salser, and K. R. Yamamoto. 1988. A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell 54:1073.
22. Eilers, M., D. Picard, K. R. Yamamoto, and J. M. Bishop. 1989. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66.
23. Superti, F. G., G. Bergers, D. Picard, and M. Busslinger. 1991. Hormone-dependent transcriptional regulation and cellular transformation by Fos-steroid receptor fusion proteins. Proc. Natl. Acad. Sci. USA 88:5114.
24. Umek, R. M., A. D. Friedman, and S. L. McKnight. 1991. CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251:288.
25. Capobianco, A. J., and T. D. Gilmore. 1993. A conditional mutant of vRel containing sequences from the human estrogen receptor. Virology 193:160.
26. Samuels, M. L., M. J. Weber, J. M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13:6241.
27. Jackson, P., D. Baltimore, and D. Picard. 1993. Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants. EMBO J. 12: 2809.
28. Parker, M. G., N. Arbuckle, S. Dauvois, P. Danielian, and R. White. 1993. Structure and function of the estrogen receptor. Ann NY Acad. Sci. 684:119.
29. Brandt, M. E., and L. E. Vickery. 1997. Cooperativity and dimerization of recombinant human estrogen receptor hormone-binding domain. J. Biol. Chem. 272:4843.